Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL3887654

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Z′-LYTE Screening Assay: Axitinib was tested using a Z′-LYTE Screening Protocol (Invitrogen, Carlsbad, Calif.). Axitinib was prepared in 100% DMSO, and added to the reaction for a final DMSO concentration of 1%. Inhibitor concentrations varied from 1.0 μM to 0.00003 μM. Typical reactions were 10 μL, contained ABL1 or ABL1 [T315I], ATP (ABL1; 10 μM and ABL1 [T315I]; 5 μM), 2.0 μM Tyr 02 peptide, 10 mM MgCl2, 1.0 mM EGTA, 0.01% BRIJ-35, 1% DMSO in 50 mM HEPES pH 7.5. The mixture was incubated in a 384-well polypropylene plate at room temperature for an hour and terminated by the addition of 5 μL of a 1:64 dilution of the development reagent utilized with Z′-LYTE® Screening Protocol, followed by a 30 second shake.
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Confidence 8 — Homologous single protein target
Curated By Autocuration

Target

Tyrosine-protein kinase ABL1 (CHEMBL1862)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia
(2015)

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 1 9.38 9.38

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL1289926 AXITINIB 4.0 1 9.38

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL1289926 AXITINIB IC50 = 0.418 nM 9.38